Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New MRI-Guided radiation aims to tame tough prostate cancer with fewer side effects

NCT ID NCT07132073

First seen May 01, 2026 · Last updated Jun 18, 2026 · Updated 7 times

Summary

This study tests a precise radiation technique that uses MRI guidance to treat unfavorable prostate cancer. It combines two types of radiation (brachytherapy and SBRT) to improve convenience and reduce side effects. The goal is to keep 85% of the 40 participants cancer-free for 5 years while lowering severe urinary and rectal problems. The approach is designed for patients who are not ideal candidates for standard high-dose therapy, such as older or frail individuals.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Clínica Universidad de Navarra Cancer Center

    Pamplona, Foral Community of Navarre, 31008, Spain

Conditions

The condition(s) this trial relates to.

prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.